What is Immutep Ltd - ADR (IMMP)?
Immutep Ltd is a biotechnology company specializing in the development of immunotherapies for cancer and autoimmune diseases. The company focuses on LAG-3 (lymphocyte activation gene-3) pathway modulators, aiming to regulate immune responses for therapeutic benefit. Immutep's pipeline includes multiple clinical-stage candidates targeting various indications, including solid tumors and chronic inflammatory conditions. The company employs a range of modalities such as agonists and antagonists to modulate immune checkpoints. Immutep collaborates with pharmaceutical partners and research institutions to advance its programs through clinical development and commercialization. Headquartered in Australia, the company operates internationally within the biopharmaceutical sector. Its research emphasizes innovative approaches to harness the immune system for disease treatment, contributing to the broader field of immuno-oncology and immunotherapy.
Immutep Ltd - ADR Stock Price Today: Live Overview
The price today is shaped by current trading levels with Humm Group Ltd priced at $0.43. The stock has fluctuated between $0.38 and $0.39 during the session, marking a daily change of 0%.
FAQ: Immutep Ltd - ADR (IMMP)
What is the current price of IMMP stock?
The current price stands at $0.43.
Does IMMP pay dividends?
Immutep Ltd pays dividends via cash distributions (if applicable).
Does IMMP have a formal corporate presence or regional headquarters in the UAE?
Immutep Ltd operates in the UAE through distributors and does not maintain an official office or subsidiary.
What is IMMP best known for?
Immutep Ltd is most famous for its development of immunotherapy products targeting LAG-3.
What assets are typically shown together with IMMP?
Commonly shown alongside IMMP: Lindblad Expeditions Holdings Inc, Sabra Health Care REIT Inc, Horace Mann Educators Corp
Latest shares articles



